tiprankstipranks
Trending News
More News >
Sellas Life Sciences Group (SLS)
NASDAQ:SLS
US Market

SELLAS Life Sciences Group (SLS) Income Statement

Compare
1,372 Followers

SELLAS Life Sciences Group Income Statement

Last quarter (Q4 2025), SELLAS Life Sciences Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, SELLAS Life Sciences Group's net income was $-7.66M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.00M$ 7.60M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 900.00K$ 7.40M
Operating Expenses
$ 28.27M$ 31.51M$ 37.87M$ 42.85M$ 32.69M
Depreciation and Amortization
$ 0.00$ 31.51M$ 37.87M$ 457.00K$ 1.27M
EBITDA
$ -28.27M$ 632.00K$ 529.00K$ -31.49M$ -18.32M
Operating Income
$ -28.27M$ -31.51M$ -37.87M$ -41.95M$ -25.29M
Other Income/Expenses
$ 1.41M$ 632.00K$ 529.00K$ 649.00K$ 4.36M
Pretax Income
$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.94M
Net Income
$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.70M
Per Share Metrics
Basic EPS
$ -0.25$ -0.50$ -1.34$ -2.13$ -1.34
Diluted EPS
$ -0.25$ -0.50$ -1.34$ -2.13$ -1.34
Weighted Average Shares Outstanding
109.05M 61.20M 27.78M 19.39M 15.48M
Weighted Average Shares Outstanding (Diluted)
109.05M 61.20M 27.78M 19.40M 15.48M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History